Imbria Pharmaceuticals

After a six-month search to find a permanent replacement for research chief John Reed, Sanofi has dipped into the venture capital sector and appointed Houman Ashrafian as its new head of R&D, effect

A new UK-based company, RQ Biotechnology, has emerged from stealth mode via a deal with AstraZeneca to license six early-stage COVID-19 monoclonal antibody candidates worth up to $157m plus royaltie